MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.
EIGRQ
Stock ticker:
PRICE
CHANGE
CAPITALIZATION

Eiger BioPharmaceuticals (EIGRQ) Ownership - Who owns Eiger BioPharmaceuticals?

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.59M
P/E Ratio
N/A
Total Cash
2.13M
Projected Growth
N/A
Total Debt
41.2M
Revenue
15.77M
Risk (Beta)
3.52
Dividend Yield
N/A
Total Cash/Share
1.44
Total Debt/Equity
N/A
Revenue/Share
4.32 USD as % of share price

Fundamentals

EIGRQ
Capitalization
12.6M
P/E Ratio
N/A
Risk (Beta)
3.52
Dividend Yield
N/A
Total Cash
2.13M
Total Cash/Share
1.44
Total Debt
41.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.32%
Revenue
15.8M
ROE
N/A
Book Value
-14.46M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-50.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
0.71
Current Revenue Per Employee
152120.00
Dividends Per Share - Security
N/A
EBITDA
-68.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
97.34
Revenue To Assets
-94.31
Shares Held By Institutions
1.99M
Shares Outstanding - Current
1.48M
Total Liabilities
53.3M
Total Volume MTD
N/A
Value
1
Gain YTD
26.206
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details